Comparison of Contemporary Drug-eluting Coronary Stents - Is Any Stent Better than the Others?
Ontology highlight
ABSTRACT: Percutaneous coronary intervention (PCI) with implantation of a metallic drug-eluting stent (DES) is the mainstay of treatment in patients with significant coronary artery disease or acute coronary syndromes. DESs comprise a metallic platform and an anti-proliferative drug, usually released from a polymer coating. A wide range of DESs, differing in platform, polymer or drug, are currently available for clinical use. Although there are significant differences in the physical, biological and pharmacological properties of contemporary DESs, it remains unclear whether these impact meaningfully on clinical outcomes for patients undergoing PCI. Numerous randomised clinical trials have compared DESs in recent years, but these trials are typically designed to show non-inferiority, rather than supe
SUBMITTER: Parker W
PROVIDER: S-EPMC9524693 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA